.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,763,569

« Back to Dashboard

Details for Patent: 5,763,569

Title: Calcium receptor-active molecules
Abstract:The present invention features calcium receptor polypeptides and fragments thereof. Uses of a calcium receptor polypeptide include providing a polypeptide having the activity of a calcium receptor polypeptide. Calcium receptor polypeptide fragments can be used, for example, to generate antibodies to a calcium receptor polypeptide.
Inventor(s): Brown; Edward M. (Milton, MA), Hebert; Steven C. (Wellesley, MA), Garrett, Jr.; James E. (Salt Lake City, UT)
Assignee: The Brigham and Women's Hospital, Inc (Boston, MA) NPS Pharmaceuticals, Inc. (Salt Lake City, UT)
Filing Date:Jun 07, 1995
Application Number:08/484,565
Claims:1. A purified polypeptide comprising at least 12 contiguous amino acids of an amino acid sequence provided in SEQ ID NO: 5.

2. The purified polypeptide of claim 1 comprising at least 18 contiguous amino acids of said amino acid sequence.

3. The purified polypeptide of claim 2 comprising at least 54 contiguous amino acids of said amino acid sequence.

4. A purified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8.

5. The polypeptide of claim 4, wherein said amino acid sequence is SEQ ID NO: 5.

6. The polypeptide of claim 4, wherein said amino acid sequence is SEQ ID NO: 6.

7. The polypeptide of claim 4, wherein said amino acid sequence is SEQ ID NO: 7.

8. The polypeptide of claim 4, wherein said amino acid sequence is SEQ ID NO: 8.

9. A purified polypeptide consisting of an amino acid sequence selected from the group consisting of: SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8.

10. The polypeptide of claim 9, wherein said amino acid sequence is SEQ ID NO: 5.

11. The polypeptide of claim 9, wherein said amino acid sequence is SEQ ID NO: 6.

12. The polypeptide of claim 9, wherein said amino acid sequence is SEQ ID NO: 7.

13. The polypeptide of claim 9, wherein said amino acid sequence is SEQ ID. NO: 8.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc